New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 18, 2013
16:36 EDTAGNFDA approves Botox to treat overactive bladder
The U.S. Food and Drug Administration expanded the approved use of Botox to treat adults with overactive bladder who cannot use or do not adequately respond to a class of medications known as anticholinergics. Botox’s safety and effectiveness for this new indication were established in two clinical trials of 1,105 patients with symptoms of overactive bladder. Patients were randomly assigned to receive injections of 100 units of Botox or placebo. Botox is manufactured by Allergan (AGN). Reference Link
News For AGN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 23, 2015
16:14 EDTAGNPershing Square liquidates stake in Allergan
Subscribe for More Information
09:03 EDTAGNLeerink analysts hold a meeting with a conference call hookup
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use